New York-based UpHealth brings patient management software to India's Nagaland
HelloLyf, a patient management, digital health and decision support software by New York-listed digital health firm UpHealth, has come to the state of Nagaland in India with the opening of the company's latest health facility there.
The digital hospital HelloLyf HX provides outpatient care, emergency care, radiology...
The Digital Medicine Society (DiMe) is teaming up with pharma giants AbbVie, Janssen Research and Development, Novartis, Pfizer and UCB to make nocturnal scratch an endpoint for atopic dermatitis.
Atopic dermatitis, also known as eczema, can lead to nighttime itches and scratching, which impact the quality of a patient's sleep. Recent studies have outlined wearable sensors’ role in helping to...
ConcertAI, a healthcare data science and AI company that focuses on oncology, is expanding its partnership with Janssen Research & Development to improve study design and diversify clinical trials.
The company, formerly known as Concerto HealthAI, said the collaboration will allow it to expand its data sources, move into disease states at earlier stages and provide more access to new...
Janssen, Johnson & Johnson’s pharma subsidiary, is looking to the digital health startup space for new ideas on predictive diagnostics and precision treatment. The company has launched a new nine-month startup accelerator focused on the Europe, Middle East and Africa (EMEA) region.
Startups will have until Sept 27 to apply to the accelerator and must focus their pitch around ways to improve...
Apple and Johnson & Johnson announced this morning the launch of their new digital health study exploring the impact of Apple’s devices and a study-specific engagement program on cardiovascular outcomes among the Medicare population.
First announced in early 2019, the Heartline Study — which also names Evidation Health as a collaborator — is now enrolling seniors aged 65 years or older who...
Due to the promises of lower costs, simple scaling and greater patient engagement, digital technologies are all but an inevitability for the drug trials of tomorrow, according to experts from pharma and the clinical research community speaking this weekend at the American Heart Association Scientific Sessions in Philadelphia.
These comments were accompanied by the official kickoff of CHIEF-HF,...
Singapore-headquartered digital health and data analytics company Holmusk signed a Memorandum of Understanding (MoU) with Janssen (China) Research & Development Centre (Janssen), to explore the development of a digital mental health strategy in China.
Based on the MoU, Holmusk and Janssen propose to focus on generating insights from real-world data on depression and other mental health...
Janssen Research and Development, a Johnson & Johnson subsidiary, will launch the first clinical trial to use its iSTEP technology toolset, which employs smart blisterpacks and a patient-facing smartphone app, by the end of the year. iSTEP, which stands for Integrated Smart Trial and Engagement Platform, has been under development at Janssen for five years.
“The mission of Janssen as an...
Japanese health app maker Welby announced three new apps last month developed in partnership with pharma companies. Welby will add to its lineup three apps available only in Japan: an app for irritable bowel disease patients with Johnson & Johnson subsidiary Janssen; an app for pulmonary arterial hypertension (PAH) patients with Japanese pharma company Nippon Shinyaku, and an app for...
Omniscience Mobile's upcoming clinical trial app.
Mobile technology presents a sorely-needed, long-awaited opportunity for innovating the clinical trial – making it cheaper, easier, and even more accurate. But there are a lot of pieces to a clinical trial, and, according to some, mobile technology has the capacity to influence almost every one. Different companies are experimenting with these...
